Lumexa Imaging Holdings, Inc.

For the period ended Mar 31, 2026. Filed May 12, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 12, 2026

LMRI$13.92-0.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements Operations and Comprehensive Income (Loss)

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited)

(in thousands, except for share and per share data)

	THREE MONTHS ENDEDMARCH 31,
	2026	2025
REVENUES:
Net patient service revenue	$188,992	$184,217
Net patient service revenue, related party	8,326	8,081
Management fee and other revenue	5,677	5,323
Management fee and other revenue, related party	49,542	47,380
Total revenues	252,537	245,001
OPERATING EXPENSES:
Cost of operations, excluding depreciation and amortization	217,755	208,397
General and administrative expenses	20,335	17,492
Depreciation and amortization	9,922	9,051
Loss (gain) on disposal of property and equipment	137	(162)
Total operating expenses	248,149	234,778
Equity in earnings of unconsolidated affiliates	15,024	15,318
INCOME FROM OPERATIONS	19,412	25,541
OTHER EXPENSES:
Interest expense	16,331	29,849
INCOME (LOSS) BEFORE INCOME TAXES	3,081	(4,308)
Income tax provision	1,364	3,379
NET INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS)	$1,717	$(7,687)
Weighted average shares outstanding:
Basic	95,983,233	69,523,369
Diluted	95,983,243	69,523,369
Net income (loss) per common share:
Basic	$0.02	$(0.11)
Diluted	$0.02	$(0.11)

LUMEXA IMAGIng holdings, inc. AND SUBSIDIARIES

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.